Anti-CD82 antibody [EPR4112]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal CD82 antibody. Suitable for WB and reacts with Human samples. Cited in 4 publications.
View Alternative Names
CD82, KAI1, SAR2, ST6, TSPAN27, CD82 antigen, C33 antigen, IA4, Inducible membrane protein R2, Metastasis suppressor Kangai-1, Suppressor of tumorigenicity 6 protein, Tetraspanin-27, Tspan-27
- WB
Unknown
Western blot - Anti-CD82 antibody [EPR4112] (AB109529)
Lanes 1 - 5:
Western blot - Anti-CD82 antibody [EPR4112] (ab109529) at 1/1000 dilution
Lanes 6 - 7:
Western blot - Anti-CD82 antibody [EPR4112] - BSA and Azide free (<a href='/en-us/products/primary-antibodies/cd82-antibody-epr4112-bsa-and-azide-free-ab226072'>ab226072</a>) at 1/1000 dilution
Lane 1:
U-87 MG (Human glioblastoma-astrocytoma epithelial cell) whole cell lysate
Lane 2:
Jurkat (Human T cell leukemia T lymphocyte) whole cell lysate
Lane 3:
Raji (Human Burkitt's lymphoma B lymphocyte) whole cell lysate
Lane 4:
SW480 (Human colorectal adenocarcinoma epithelial cell) whole cell lysate
Lane 5:
HT-29 (Human colorectal adenocarcinoma epithelial cell) whole cell lysate
Lane 6:
RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate
Lane 7:
C6 (Rat glial tumor glial cell) whole cell lysate
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 29 kDa
false
- WB
CiteAb
Western blot - Anti-CD82 antibody [EPR4112] (AB109529)
CD82 western blot using anti-CD82 antibody [EPR4112] ab109529. Publication image and figure legend from Ding, C., Cheng, S., et al., 2014, Int J Mol Sci, PubMed 24663081.
ab109529 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab109529 please see the product overview.
Upregulation of QKI, CD82, and RBM38 were validated after knockdown of HOTAIR. (A) Bel-7402 cells; (B) HepG2 cells were transiently transfected with HOTAIR siRNA for 48 h to detect QKI, CD82, and RBM38 expression by qRT-PCR compared with the siGFP group (* indicated p < 0.05); and (C) showed the protein level of QKI, CD82, and RBM38 after HOTAIR knockdown in Bel-7402 cells by Western blot. All experiments were performed in triplicates.
false
Related conjugates and formulations (1)
-
Anti-CD82 antibody [EPR4112] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD82 plays a significant role in regulating cell signaling and communication during tumor progression and metastasis. It participates in the formation of tetraspanin-enriched microdomains by associating with other tetraspanins and integrins influencing the cellular microenvironment. Additionally CD82 impacts immune cell interactions by modulating activities of T cells and B cells. Despite not being the predominant component in any major protein complex CD82 influences many cellular processes by regulating diverse signaling pathways.
Pathways
CD82 modulates both the PI3K-Akt signaling pathway and the Wnt signaling pathway. These pathways are critical in controlling cellular processes like growth and survival contributing to the metastasis-suppressive effects of CD82. In these contexts CD82 associates with proteins such as integrins and cadherins which facilitate its regulation of signal transduction and cellular dynamics. CD82's role in these pathways shows its importance in controlling cancer cell behavior and immune system interactions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Glia 72:692-707 PubMed38192185
2024
Applications
Unspecified application
Species
Unspecified reactive species
Technology in cancer research & treatment 20:15330338211045204 PubMed34605330
2021
Applications
Unspecified application
Species
Unspecified reactive species
Disease markers 2020:8899924 PubMed33204367
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 15:4060-76 PubMed24663081
2014
Applications
WB
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com